| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman &CEO | Sell | 4,707 | $108.41 | $510,281.79 | - | |
| Feb 27, 2018 | CRL Charles River Laboratories International, Inc. | Smith David Ross63 | Corporate Executive VP &CFO | Sell | 2,158 | $108.10 | $233,282.54 | -0.7% | |
| Feb 27, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman &CEO | Sell | 7,067 | $108.15 | $764,279.88 | - | |
| Feb 27, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman &CEO | Sell | 3,810 | $107.66 | $410,199.22 | - | |
| Feb 27, 2018 | RVTY Revvity, Inc. | Michas Alexis P68 | Director | Sell | 2,412 | $77.35 | $186,568.20 | -4.2% | |
| Feb 27, 2018 | EXAS Exact Sciences Corp | Lidgard Graham Peter | Chief Science Officer | Sell | 35,025 | $42.88 | $1,501,960.29 | -4.1% | |
| Feb 27, 2018 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 9,085 | $44.10 | $400,630.33 | -1.0% | |
| Feb 27, 2018 | EXAS Exact Sciences Corp | Arora Maneesh | COO | Sell | 5,512 | $44.10 | $243,068.18 | -0.9% | |
| Feb 27, 2018 | EXAS Exact Sciences Corp | Coward D Scott77 | SVP And General Counsel | Sell | 9,292 | $44.10 | $409,758.62 | -13.2% | |
| Feb 26, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman &CEO | Sell | 4,800 | $106.69 | $512,123.05 | - | |
| Feb 26, 2018 | IQV Iqvia Holdings Inc. | Erlinger III James H | See Remarks | Sell | 10,000 | $100.00 | $1,000,000.00 | -42.6% | |
| Feb 26, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman &CEO | Sell | 5,727 | $107.00 | $612,778.99 | - | |
| Feb 26, 2018 | DHR Danaher Corp /de/ | Schwieters John T | Director | Sell | 10,578 | $100.30 | $1,060,983.98 | -35.8% | |
| Feb 26, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman &CEO | Sell | 900 | $108.81 | $97,929.00 | - | |
| Feb 26, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman &CEO | Sell | 5,269 | $107.85 | $568,287.16 | - | |
| Feb 26, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman &CEO | Sell | 4,429 | $108.43 | $480,231.75 | - | |
| Feb 26, 2018 | CRL Charles River Laboratories International, Inc. | Smith David Ross63 | Corporate Executive VP &CFO | Sell | 3,868 | $107.35 | $415,224.08 | -0.8% | |
| Feb 26, 2018 | CRL Charles River Laboratories International, Inc. | Smith David Ross63 | Corporate Executive VP &CFO | Sell | 319 | $108.53 | $34,620.00 | -0.7% | |
| Feb 26, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman &CEO | Sell | 3,999 | $107.31 | $429,134.63 | - | |
| Feb 26, 2018 | DHR Danaher Corp /de/ | Blair Rainer63 | Executive Vice President | Sell | 3,981 | $100.05 | $398,295.07 | -8.2% | |
| Feb 26, 2018 | EXAS Exact Sciences Corp | Coward D Scott77 | SVP And General Counsel | Sell | 4,420 | $42.34 | $187,133.96 | -8.3% | |
| Feb 26, 2018 | EXAS Exact Sciences Corp | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sell | 2,982 | $42.34 | $126,251.92 | -12.4% | |
| Feb 26, 2018 | EXAS Exact Sciences Corp | Arora Maneesh | COO | Sell | 12,352 | $42.34 | $522,958.98 | -1.9% | |
| Feb 26, 2018 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 25,319 | $42.34 | $1,071,955.82 | -2.9% | |
| Feb 26, 2018 | EXAS Exact Sciences Corp | Lidgard Graham Peter | Chief Science Officer | Sell | 27,428 | $40.44 | $1,109,266.16 | -4.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.